Used primarily in pharmaceutical research as a potent inhibitor of monoamine oxidase enzymes, particularly MAO-B. This compound shows promise in the development of treatments for neurodegenerative disorders such as Parkinson’s disease due to its ability to protect neurons and modulate neurotransmitter levels. Its trifluoromethylbenzyl and methylindoline-dione structure enhances blood-brain barrier penetration and metabolic stability, making it a valuable scaffold in CNS drug design. Additionally, it has been investigated for anti-inflammatory and anticancer properties in preclinical studies, especially in models involving oxidative stress and apoptosis regulation.